Answers are grounded in this paper and cite their sources.
Study evaluated mass spectrometry systems for identifying Candida species, indicating variations in effectiveness.
Aim: Distinction of species within the Candida glabrata complex (i.e., C. glabrata sensu stricto, Candida nivariensis and Candida bracarensis) is relevant for epidemiological purposes and antifungal management. Materials & methods: Two commercial matrix-assisted laser desorption ionization–time of flight mass spectrometry systems were comprehensively evaluated for the identification of fungi within this complex. Results: None of the species (C. nivariensis and C. bracarensis) were identified correctly by Vitek mass spectrometry (MS®) v2.0 In Vitro Diagnosis system and Bruker Biotyper MS® v3.1, but all were correct by the Vitek MS® Research Use Only system. The Bruker ClinProTools software showed 100% recognition capability and cross validation for the discrimination of C. nivariensis and C. bracarensis. Conclusion: Using Vitek MS Research Use Only and Bruker ClinProTools can overcome limitations of the Vitek MS In Vitro Diagnosis and Bruker Biotyper databases in the identification of C. glabrata complex.
No takes yet. Share an insight, caveat, or question.
Hou et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: